Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 15

1.

Efficacy of an implantable cardioverter-defibrillator in a neonate with LQT3 associated arrhythmias.

Ten Harkel AD, Witsenburg M, de Jong PL, Jordaens L, Wijman M, Wilde AA.

Europace. 2005 Jan;7(1):77-84.

PMID:
15670972
2.

Is there a role for implantable cardioverter defibrillators in long QT syndrome?

Welde AA.

J Cardiovasc Electrophysiol. 2002 Jan;13(1 Suppl):S110-3. Review.

PMID:
11852886
3.

Role of implantable cardioverter defibrillator therapy in patients with long QT syndrome.

Daubert JP, Zareba W, Rosero SZ, Budzikowski A, Robinson JL, Moss AJ.

Am Heart J. 2007 Apr;153(4 Suppl):53-8. Review.

PMID:
17394903
4.

Antiarrhythmic drugs in patients with implantable cardioverter-defibrillators.

Bollmann A, Husser D, Cannom DS.

Am J Cardiovasc Drugs. 2005;5(6):371-8. Review.

PMID:
16259525
5.

Implantable cardioverter-defibrillators in children.

Blom NA.

Pacing Clin Electrophysiol. 2008 Feb;31 Suppl 1:S32-4. doi: 10.1111/j.1540-8159.2008.00952.x. Review.

PMID:
18226032
6.

Experience with implantable cardioverter-defibrillator therapy in grown-ups with congenital heart disease.

Tomaske M, Bauersfeld U.

Pacing Clin Electrophysiol. 2008 Feb;31 Suppl 1:S35-7. doi: 10.1111/j.1540-8159.2008.00953.x. Review.

PMID:
18226033
7.

Implantable cardioverter defibrillator therapy in athletes.

Heidbüchel H.

Cardiol Clin. 2007 Aug;25(3):467-82, vii. Review.

PMID:
17961801
8.

Short QT syndrome.

Schimpf R, Wolpert C, Gaita F, Giustetto C, Borggrefe M.

Cardiovasc Res. 2005 Aug 15;67(3):357-66. Review.

PMID:
15890322
10.

Implantable cardioverter defibrillator therapy and the need for concomitant antiarrhythmic drugs.

Singh S, Murawski MM.

J Cardiovasc Pharmacol Ther. 2007 Sep;12(3):175-80. Review.

PMID:
17875944
11.

[Frequent ventricular tachycardias: antiarrhythmic drug treatment or catheter ablation?].

Tanner H, Hindricks G, Kottkamp H.

Herz. 2005 Nov;30(7):613-8. Review. German.

PMID:
16333587
12.

Subcutaneous implantable cardioverter defibrillators in children, young adults and patients with congenital heart disease.

Bordachar P, Marquié C, Pospiech T, Pasquié JL, Jalal Z, Haissaguerre M, Thambo JB.

Int J Cardiol. 2016 Jan 15;203:251-8. doi: 10.1016/j.ijcard.2015.09.083. Epub 2015 Sep 26. Review.

PMID:
26519678
14.

Heart Rhythm Society/Pediatric and Congenital Electrophysiology Society Clinical Competency Statement: training pathways for implantation of cardioverter-defibrillators and cardiac resynchronization therapy devices in pediatric and congenital heart patients.

Saul JP, Epstein AE, Silka MJ, Berul CI, Dick M 2nd, Dimarco JP, Friedman RA, Rosenthal E, Stephenson EA, Vetter VL; American College of Cardiology; American Heart Association; Heart Rhythm Society; Pediatric and Congenital Electrophysiology Society.

Heart Rhythm. 2008 Jun;5(6):926-33. doi: 10.1016/j.hrthm.2008.04.012. Epub 2008 May 8. Review. No abstract available.

PMID:
18479976
15.

MY APPROACH to treatment of the congenital long QT syndromes.

Ackerman MJ.

Trends Cardiovasc Med. 2015 Jan;25(1):67-9. doi: 10.1016/j.tcm.2014.07.007. Epub 2014 Sep 6. Review. No abstract available.

PMID:
25442736

Supplemental Content

Support Center